Diseases
Cancer is a group of diseases in which there are an uncontrolled division and multiplication of cells in the body.
Nowadays, cannabinoids are being used as palliative medicine, thanks to their analgesic and antiemetic effect. But several studies indicate that they have other properties that may be of interest in combating cancer cells.
Therefore, there is a substantial increase in scientific studies for medical use of the Cannabis plant. However, more studies must be carried out, since at the moment there are many cases without precise data at a preclinical and clinical level that guarantee their anti-cancer characteristics reliably.
The cannabinoid CBD is the one with antitumor properties. In preclinical models, it has been possible to demonstrate antitumor activity in different types of tumors, such as brain (gliomas), skin (cutaneous melanoma and carcinoma), breast, pancreas, liver, and prostate, among others.
Cannabinoids activate the CB1 and CB2 receptors in the tumor cells, starting a complex intracellular signaling pathway that causes cell death.
Besides inducing the death of tumor cells, cannabinoids also inhibit the secretion of VEGF factor, needed to form blood vessels specific to cancer. Thus blocking the supply of nutrients necessary for tumor growth.
A third antitumor effect is the cannabinoids’ ability to modulate the activity of certain enzymes (metalloproteases), involved in remodeling the extracellular matrix, an important aspect for the migratory and invasive capacity of the tumor.
Cannabinoids could provide beneficial effects as a coadjuvant treatment in some types of tumors (brain gliomas, for example). Some animal studies have shown that cannabinoids can enhance both chemotherapy and radiotherapy.
In the palliative treatment of tumors, cannabinoids improve chemotherapy symptoms such as nausea, vomiting, inappetence, physical pain or insomnia.